@JPSwcpmc Yes! Looking fwd to the reveal on REDUCE-IT data and hoping to hear an update on their EVAPORATE trial i.e enrollment. EVAPORATE has an efficacy readout at 9 months, I believe. Should align with these results: https://t.co/RnMKcptYYI $AMRN
So far, Altmetric has seen 6 tweets from 4 users, with an upper bound of 6,168 followers.